Claudia Wing

Claudia Wing

Auto-generated profile, based on publicly available information

Claudia Wing

Department of Medicine/Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2015 in JAMA
Verified
Journal Article
Open access
PDF file
BDBarthelemy Diouf
Barthelemy Diouf
KCKristine R. Crews
Kristine R. Crews
GLGlen Lew
Glen Lew
DPDeqing Pei
Deqing Pei
CCCheng Cheng
Cheng Cheng
WEWilliam E. Evans
William E. Evans
Cancer remains the leading cause of death by disease in US children despite major advances in the last 20 years. Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and as cure rates have surpassed 85%,1,2 it becomes increasingly important to mitigate the acute and chronic toxicities of treatment that adversely affect quality of life and longevity. Vincristine is one of the most widely used and effective anticancer agents for treating leukemias, lymphomas, brain tumors, and solid tumors in both adults and children1,2 and is administered multiple times as part of treatment protocols for every child with ALL and for children with neuroblastoma, Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, and retinoblastoma.3

1 July 2011 in RNA Biology
Verified
Journal Article
Closed access
RHR. Stephanie Huang
R. Stephanie Huang
EGEric Gamazon
Eric Gamazon
DZDana Ziliak
Dana Ziliak
YWYujia Wen
Yujia Wen
HIHae Kyung Im
Hae Kyung Im
MDM. Eileen Dolan
M. Eileen Dolan
Population differences observed for complex traits may be attributed to the combined effect of socioeconomic, environmental, genetic and epigenetic factors. To better understand population differen...

1 August 2013 in Genetics
Verified
Journal Article
Open access
PDF file
EMErika L. Moen
Erika L. Moen
XZXu Zhang
Xu Zhang
WMWenbo Mu
Wenbo Mu
SDShannon M. Delaney
Shannon M. Delaney
CWClaudia Wing
Claudia Wing
WZWei Zhang
Wei Zhang
Elucidating cytosine modification differences between human populations can enhance our understanding of ethnic specificity in complex traits. In this study, cytosine modification levels in 133 HapMap lymphoblastoid cell lines derived from individuals of European or African ancestry were profiled using the Illumina HumanMethylation450 BeadChip. Approximately 13% of the analyzed CpG sites showed differential modification between the two populations at a false discovery rate of 1%. The CpG sites with greater modification levels in European descent were enriched in the proximal regulatory regions, while those greater in African descent were biased toward gene bodies. More than half of the detected population-specific cytosine modifications could be explained primarily by local genetic variation. In addition, a substantial proportion of local modification quantitative trait loci exhibited population-specific effects, suggesting that genetic epistasis and/or genotype × environment interactions could be common. Distinct correlations were observed between gene expression levels and cytosine modifications in proximal regions and gene bodies, suggesting epigenetic regulation of interindividual expression variation. Furthermore, quantitative trait loci associated with population-specific modifications can be colocalized with expression quantitative trait loci and single nucleotide polymorphisms previously identified for complex traits with known racial disparities. Our findings revealed abundant population-specific cytosine modifications and the underlying genetic basis, as well as the relatively independent contribution of genetic and epigenetic variations to population differences in gene expression.

6 March 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RWRichard Williams
Richard Williams
JLJackie E. Lim
Jackie E. Lim
BHBettina Harr
Bettina Harr
CWClaudia Wing
Claudia Wing
RWRyan Walters
Ryan Walters
APAbraham A. Palmer
Abraham A. Palmer
Glyoxalase 1 (Glo1) has been implicated in anxiety-like behavior in mice and in multiple psychiatric diseases in humans. We used mouse Affymetrix exon arrays to detect copy number variants (CNV) among inbred mouse strains and thereby identified a ∼475 kb tandem duplication on chromosome 17 that includes Glo1 (30,174,390–30,651,226 Mb; mouse genome build 36). We developed a PCR-based strategy and used it to detect this duplication in 23 of 71 inbred strains tested, and in various outbred and wild-caught mice. Presence of the duplication is associated with a cis-acting expression QTL for Glo1 (LOD>30) in BXD recombinant inbred strains. However, evidence for an eQTL for Glo1 was not obtained when we analyzed single SNPs or 3-SNP haplotypes in a panel of 27 inbred strains. We conclude that association analysis in the inbred strain panel failed to detect an eQTL because the duplication was present on multiple highly divergent haplotypes. Furthermore, we suggest that non-allelic homologous recombination has led to multiple reversions to the non-duplicated state among inbred strains. We show associations between multiple duplication-containing haplotypes, Glo1 expression and anxiety-like behavior in both inbred strain panels and outbred CD-1 mice. Our findings provide a molecular basis for differential expression of Glo1 and further implicate Glo1 in anxiety-like behavior. More broadly, these results identify problems with commonly employed tests for association in inbred strains when CNVs are present. Finally, these data provide an example of biologically significant phenotypic variability in model organisms that can be attributed to CNVs.

17 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HWHeather E. Wheeler
Heather E. Wheeler
CWClaudia Wing
Claudia Wing
SDShannon M. Delaney
Shannon M. Delaney
MKMasaaki Komatsu
Masaaki Komatsu
MDM. Eileen Dolan
M. Eileen Dolan
There are no effective agents to prevent or treat chemotherapy-induced peripheral neuropathy (CIPN), the most common non-hematologic toxicity of chemotherapy. Therefore, we sought to evaluate the utility of human neuron-like cells derived from induced pluripotent stem cells (iPSCs) as a means to study CIPN. We used high content imaging measurements of neurite outgrowth phenotypes to compare the changes that occur to iPSC-derived neuronal cells among drugs and among individuals in response to several classes of chemotherapeutics. Upon treatment of these neuronal cells with the neurotoxic drug paclitaxel, vincristine or cisplatin, we identified significant differences in five morphological phenotypes among drugs, including total outgrowth, mean/median/maximum process length, and mean outgrowth intensity (P < 0.05). The differences in damage among drugs reflect differences in their mechanisms of action and clinical CIPN manifestations. We show the potential of the model for gene perturbation studies by demonstrating decreased expression of TUBB2A results in significantly increased sensitivity of neurons to paclitaxel (0.23 ± 0.06 decrease in total neurite outgrowth, P = 0.011). The variance in several neurite outgrowth and apoptotic phenotypes upon treatment with one of the neurotoxic drugs is significantly greater between than within neurons derived from four different individuals (P < 0.05), demonstrating the potential of iPSC-derived neurons as a genetically diverse model for CIPN. The human neuron model will allow both for mechanistic studies of specific genes and genetic variants discovered in clinical studies and for screening of new drugs to prevent or treat CIPN.

9 August 2005 in FEBS Letters
Verified
Journal Article
Open access
PDF file
SLSanggyu Lee
Sanggyu Lee
DJDebra Johnson
Debra Johnson
KDK. Dunbar
K. Dunbar
HDHui Dong
Hui Dong
XGXijin Ge
Xijin Ge
SWSan Ming Wang
San Ming Wang
The biological effect of radiofrequency (RF) fields remains controversial. We address this issue by examining whether RF fields can cause changes in gene expression. We used the pulsed RF fields at a frequency of 2.45 GHz that is commonly used in telecommunication to expose cultured human HL‐60 cells. We used the serial analysis of gene expression (SAGE) method to measure the RF effect on gene expression at the genome level. We observed that 221 genes altered their expression after a 2‐h exposure. The number of affected genes increased to 759 after a 6‐h exposure. Functional classification of the affected genes reveals that apoptosis‐related genes were among the upregulated ones and the cell cycle genes among the downregulated ones. We observed no significant increase in the expression of heat shock genes. These results indicate that the RF fields at 2.45 GHz can alter gene expression in cultured human cells through non‐thermal mechanism.